Earlier cancer diagnosis in primary care: a feasibility economic analysis of ThinkCancer!
- PMID: 36543386
- PMCID: PMC10354333
- DOI: 10.3399/BJGPO.2022.0130
Earlier cancer diagnosis in primary care: a feasibility economic analysis of ThinkCancer!
Abstract
Background: UK cancer survival rates are much lower compared with other high-income countries. In primary care, there are opportunities for GPs and other healthcare professionals to act more quickly in response to presented symptoms that might represent cancer. ThinkCancer! is a complex behaviour change intervention aimed at primary care practice teams to improve the timely diagnosis of cancer.
Aim: To explore the costs of delivering the ThinkCancer! intervention to expedite cancer diagnosis in primary care.
Design & setting: Feasibility economic analysis using a micro-costing approach, which was undertaken in 19 general practices in Wales, UK.
Method: From an NHS perspective, micro-costing methodology was used to determine whether it was feasible to gather sufficient economic data to cost the ThinkCancer!
Intervention: Owing to the COVID-19 pandemic, ThinkCancer! was mainly delivered remotely online in a digital format. Budget impact analysis (BIA) and sensitivity analysis were conducted to explore the costs of face-to-face delivery of the ThinkCancer! intervention as intended pre-COVID-19.
Results: The total costs of delivering the ThinkCancer! intervention across 19 general practices in Wales was £25 030, with an average cost per practice of £1317 (standard deviation [SD]: 578.2). Findings from the BIA indicated a total cost of £34 630 for face-to-face delivery.
Conclusion: Data collection methods were successful in gathering sufficient health economics data to cost the ThinkCancer!
Intervention: Results of this feasibility study will be used to inform a future definitive economic evaluation alongside a pragmatic randomised controlled trial (RCT).
Keywords: early cancer diagnosis; feasibility studies; general practice; health care economics and organizations; primary health care.
Copyright © 2023, The Authors.
Conflict of interest statement
NHW is a GP principal in Plas Menai Health Centre, Llanfairfechan, which participated in this feasibility study. This research is linked to the CanTest Collaborative, which is funded by Cancer Research UK (C8640/A23385), of which RDN is an Associate Director.
Figures
References
-
- Welsh Government Statistical First Release. NHS expenditure programme budgets, 2017–18. 2019. https://gov.wales/sites/default/files/statistics-and-research/2019-04/nh.... [12 Jan 2023]. https://gov.wales/sites/default/files/statistics-and-research/2019-04/nh... accessed.
-
- Davies, SV, Hayes DA, Collard SB, Macmillan Cancer Cancer’s hidden price tag: Revealing the costs behind the illness. We are Macmillan. Cancer Support. 2013. https://www.macmillan.org.uk/documents/getinvolved/campaigns/costofcance.... [2 Feb 2023]. https://www.macmillan.org.uk/documents/getinvolved/campaigns/costofcance... accessed.
-
- Welsh Government Cancer delivery plan for Wales 2016–2020. The highest standard of care for everyone with cancer (Wales Cancer Network) 2016. https://www.gov.wales/sites/default/files/publications/2018-12/cancer-de.... [2 Feb 2023]. https://www.gov.wales/sites/default/files/publications/2018-12/cancer-de... accessed.
-
- Gannon B. The feasibility study: a health economics perspective. Glob Reg Health Technol Assess. 2017; 4 (1):65–68. doi: 10.5301/grhta.5000254. - DOI
LinkOut - more resources
Full Text Sources